Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioventus Inc.

7.82
+0.04000.51%
Post-market: 7.820.00000.00%19:36 EDT
Volume:323.59K
Turnover:2.52M
Market Cap:517.35M
PE:-15.05
High:7.88
Open:7.74
Low:7.59
Close:7.78
Loading ...

Company Profile

Company Name:
Bioventus Inc.
Exchange:
NASDAQ
Establishment Date:
2011
Employees:
930
Office Location:
4721 Emperor Boulevard,Suite 100,Durham,North Carolina,United States
Zip Code:
27703
Fax:
- -
Introduction:
Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices used for precise bone sculpting, removing tumors, and tissue debridement. The company's restorative therapies include a bone healing system; skin allografts; and products that are used to support healing of wounds, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Directors

Name
Position
Kenneth M. Reali
Chief Executive Officer and Director
William A. Hawkins
Director, Chairperson
David J. Parker
Director
Guido J. Neels
Director
Guy P. Nohra
Director
Martin P. Sutter
Director
Philip G. Cowdy
Director
Susan M. Stalnecker
Director

Shareholders

Name
Position
Kenneth M. Reali
Chief Executive Officer and Director
Alessandra Pavesio
Senior Vice President and Chief Science Officer
Anthony D' Adamio
Senior Vice President and General Counsel
Gregory O. Anglum
Senior Vice President and Chief Financial Officer
Katrina Church
Senior Vice President and Chief Compliance Officer
John E. Nosenzo
Chief Commercial Officer